Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Jun 2019

Divestment of a Sterile Fill / Finish Manufacturing Facility & CMO Business in León, Spain

Curia Leon

PharmaBioSource provided consulting services to Curia on the divestment of its León, Spain sterile fill / finish development and manufacturing site to LSNE.

  • Service: Transaction Consulting
  • Sector: Pharmaceuticals
  • Sub-sector: CDMO
  • Engagement Type: Sell Side

PharmaBioSource provided exclusive consulting services to divest Curia’s sterile injectables site and contract development and manufacturing business in León, Spain.  The site was acquired by LSNE (LIVIA International Ventures & Investment Activities), a global industrial holding and private investment firm. LIVIA incorporated the Lodi site into its portfolio company, Archimica, to continue operating as a CDMO.

PharmaBioSource’s services included a benchmark valuation, buyer target identification, creation of the confidential information memorandum (CIM), data room development and due diligence support.

Press Release